Biogen and AbbVie Present New Data Showing Zinbryta, an RRMS Drug Candidate, Aids Cognition Without Immune Depletion

                                                                  

Click here to receive MS news via e-mail        
 

New data presented
by Biogen and AbbVie at the recent 68th annual meeting of
the American Academy of Neurology (AAN) showed that
Zinbryta (daclizumab high-yield process) improved cognitive outcome
measures in patients with relapsing forms of multiple sclerosis (RMS).
Additional results — from post-hoc analyses of clinical trials — also
offer a better understanding of Zinbryta’s targeted mechanism of action,
showing the drug […]

The post Biogen and AbbVie Present New Data Showing Zinbryta, an
RRMS Drug Candidate, Aids Cognition Without Immune Depletion
appeared first on Multiple Sclerosis News Today.

Read on »

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News
Provides educational information, resources and services for those affected by MS
We Believe YOU (the MS Patients and Caregivers) should Be Empowered with Multiple Sclerosis information
.===================================